Determine the absolute CV risk classification for each patient and use this information to decide how aggressively to treat each patient. |
|
|
|
|
|
Implement treatment strategies tailored for special populations of patients at high CV risk. |
|
|
|
|
|
Effectively combine lipid-lowering agents that have different mechanisms of action to achieve improvements in lipid profiles. |
|
|
|
|
|
Explain how various measures for determining LDL-C (eg, calculated via Friedewald; direct LDL-C via VAP) can affect LCL-C levels and treatment decisions. |
|
|
|
|
|